Product Information
MIDODRINE HCL 2.5 MG TABLET is a generic product labeled by Xiromed LLC, priced at $0.0728 per EA under NDC 70700015701. Its NADAC has been published 293 times since Jan 13, 2021.
FDA first approved this application on Oct 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Xiromed LLCNDC
70700015701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MIDODRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207849FDA Approved
10/1/2020
TE Code
AB
On Market Since
10/15/2020
Pharmacological Classes
Price Statistics
The NADAC for MIDODRINE HCL 2.5 MG TABLET has been published 293 times since Jan 13, 2021, and over the history we have for it it has declined 71.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0728 per EA |
|---|---|
| All-time high | $0.2859 (Feb 10, 2021) |
| All-time low | $0.0668 (Nov 20, 2024) |
| 52-week high | $0.0740 |
| 52-week low | $0.0703 |
| Median price | $0.1428 |
| Average price | $0.1469 |
| Largest weekly change | +59.2% (Nov 22, 2023) |
| Weeks tracked | 293 |
| Tracking since | Jan 13, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIDODRINE HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 2.5 MG TABLET, manufactured by Xiromed LLC, is $0.0728 per EA (NDC 70700015701), effective Aug 19, 2026.
How has the price of MIDODRINE HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIDODRINE HCL 2.5 MG TABLET has declined 71.6%. It has been tracked across 293 weekly CMS publications since Jan 13, 2021.
What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 2.5 MG TABLET?
Since Jan 13, 2021, the NADAC for MIDODRINE HCL 2.5 MG TABLET has ranged from a low of $0.0668 (Nov 20, 2024) to a high of $0.2859 (Feb 10, 2021), with a median of $0.1428 per EA.
Are there cheaper alternatives to MIDODRINE HCL 2.5 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIDODRINE HCL 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIDODRINE HCL 2.5 MG TABLET?
MIDODRINE HCL 2.5 MG TABLET (NDC 70700015701) is labeled by Xiromed LLC, and CMS classifies it as a generic product.